355
Audio & Video Production344
Automation & Workflow224
Software Development250
Marketing & Growth192
AI Infrastructure & MLOps173
Writing & Content Creation203
Data & Analytics140
Design & Creative169
Customer Support130
Photography & Imaging156
Sales & Outreach125
Voice & Speech135
Operations & Admin87
Education & Learning131
SandboxAQ is integrating its science models into Claude, so researchers can run drug and materials simulations by chatting instead of setting up complex computing systems.
In short: SandboxAQ is bringing its drug discovery and materials science models into Anthropic’s Claude, so more researchers can use them through a chat-style interface.
SandboxAQ said it has teamed up with Anthropic to integrate its scientific AI models directly into Claude. Claude is Anthropic’s chatbot, a tool people can talk to in plain language.
SandboxAQ builds models it uses for drug discovery and materials science. Drug discovery is the process of finding and testing new chemical compounds that might become medicines. SandboxAQ says this work is slow and expensive, and many promising drug candidates fail after years of effort.
A key part of SandboxAQ’s approach is what it calls “large quantitative models,” or LQMs. These models are designed around physics and chemistry rules, not just patterns in text. In simple terms, they aim to act like a virtual lab bench, helping predict how a molecule might behave before a real lab runs experiments.
SandboxAQ told TechCrunch that, in the past, using these models often meant having your own computing setup to run them. With the Claude integration, the company is focusing on easier access, by letting people interact with the tools through conversation.
Many AI drug discovery tools are built for specialists who can handle complicated software and computing resources. If more scientists can use advanced simulations by “just asking” in a chat (like giving instructions to a very fast research assistant), it could lower the barrier to early research, even if it does not change the hard realities of clinical testing.
Source: TechCrunch AI